{"count": 4, "results": [{"_id": "26276089", "pmid": 26276089, "title": "Effect of metformin and adriamycin on transplantable tumor model.", "journal": "Tissue Cell", "authors": ["Kabel AM", "Omar MS", "Balaha MF", "Borg HM"], "date": "2015-10-01T00:00:00Z", "doi": "10.1016/j.tice.2015.07.003", "meta_date_publication": "2015 Oct", "meta_volume": "47", "meta_issue": "5", "meta_pages": "498-505", "score": 50072.75, "text_hl": "Eighty @CELLLINE_CVCL:4350 @@@BALB/@@@C @SPECIES_10090 @@@mice@@@ were divided into four equal groups: @<m>DISEASE_Carcinoma_Ehrlich_Tumor</m> @DISEASE_MESH:D002286 @@@SEC@@@ group, @<m>DISEASE_Carcinoma_Ehrlich_Tumor</m> @DISEASE_MESH:D002286 @@@SEC@@@+@CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@adriamycin@@@, @<m>DISEASE_Carcinoma_Ehrlich_Tumor</m> @DISEASE_MESH:D002286 @@@SEC@@@+@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @<m>DISEASE_Carcinoma_Ehrlich_Tumor</m> @DISEASE_MESH:D002286 @@@SEC@@@+@CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@adriamycin@@@+@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Kabel AM, Omar MS, Balaha MF, Borg HM. Effect of metformin and adriamycin on transplantable tumor model. Tissue Cell. 2015 Oct;47(5):498-505. PMID: 26276089", "BibTeX": "@article{26276089, title={Effect of metformin and adriamycin on transplantable tumor model.}, author={Kabel AM and Omar MS and Balaha MF and Borg HM}, journal={Tissue Cell}, volume={47}, number={5}, pages={498-505}}"}}, {"_id": "28459206", "pmid": 28459206, "title": "Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.", "journal": "Tumour Biol", "authors": ["El-Ashmawy NE", "Khedr NF", "El-Bahrawy HA", "Abo Mansour HE"], "date": "2017-05-01T00:00:00Z", "doi": "10.1177/1010428317692235", "meta_date_publication": "2017 May", "meta_volume": "39", "meta_issue": "5", "meta_pages": "1010428317692235", "score": 50058.637, "text_hl": "This work was designed to examine on molecular level the mode of action of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_10090 @@@mice@@@ bearing solid @<m>DISEASE_Carcinoma_Ehrlich_Tumor</m> @DISEASE_MESH:D002286 @@@Ehrlich carcinoma@@@ and to evaluate the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in conjunction with @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@doxorubicin@@@ as a combined therapy against solid @<m>DISEASE_Carcinoma_Ehrlich_Tumor</m> @DISEASE_MESH:D002286 @@@Ehrlich carcinoma@@@. ", "citations": {"NLM": "El-Ashmawy NE, Khedr NF, El-Bahrawy HA, Abo Mansour HE. Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway. Tumour Biol. 2017 May;39(5):1010428317692235. PMID: 28459206", "BibTeX": "@article{28459206, title={Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.}, author={El-Ashmawy NE and Khedr NF and El-Bahrawy HA and Abo Mansour HE}, journal={Tumour Biol}, volume={39}, number={5}, pages={1010428317692235}}"}}, {"_id": "28088698", "pmid": 28088698, "title": "Metformin enhancing the antitumor efficacy of carboplatin against Ehrlich solid carcinoma grown in diabetic mice: Effect on IGF-1 and tumoral expression of IGF-1 receptors.", "journal": "Int Immunopharmacol", "authors": ["Abo-Elmatty DM", "Ahmed EA", "Tawfik MK", "Helmy SA"], "date": "2017-03-01T00:00:00Z", "doi": "10.1016/j.intimp.2017.01.002", "meta_date_publication": "2017 Mar", "meta_volume": "44", "meta_issue": "", "meta_pages": "72-86", "score": 50054.84, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ enhancing the antitumor efficacy of @CHEMICAL_Carboplatin @CHEMICAL_MESH:D016190 @@@carboplatin@@@ against @<m>DISEASE_Carcinoma_Ehrlich_Tumor</m> @DISEASE_MESH:D002286 @@@Ehrlich solid carcinoma@@@ grown in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10090 @@@mice@@@: Effect on @GENE_IGF1 @GENE_16000 @@@IGF-1@@@ and tumoral expression of IGF-1 receptors.", "citations": {"NLM": "Abo-Elmatty DM, Ahmed EA, Tawfik MK, Helmy SA. Metformin enhancing the antitumor efficacy of carboplatin against Ehrlich solid carcinoma grown in diabetic mice: Effect on IGF-1 and tumoral expression of IGF-1 receptors. Int Immunopharmacol. 2017 Mar;44():72-86. PMID: 28088698", "BibTeX": "@article{28088698, title={Metformin enhancing the antitumor efficacy of carboplatin against Ehrlich solid carcinoma grown in diabetic mice: Effect on IGF-1 and tumoral expression of IGF-1 receptors.}, author={Abo-Elmatty DM and Ahmed EA and Tawfik MK and Helmy SA}, journal={Int Immunopharmacol}, volume={44}, pages={72-86}}"}}, {"_id": "20016287", "pmid": 20016287, "title": "Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo.", "journal": "Cell Cycle", "authors": ["Anisimov VN", "Egormin PA", "Piskunova TS", "Popovich IG", "Tyndyk ML", "Yurova MN", "Zabezhinski MA", "Anikin IV", "Karkach AS", "Romanyukha AA"], "date": "2010-01-01T00:00:00Z", "doi": "10.4161/cc.9.1.10407", "meta_date_publication": "2010 Jan 1", "meta_volume": "9", "meta_issue": "1", "meta_pages": "188-97", "score": 50048.297, "text_hl": "The combined treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ + @CHEMICAL_Melatonin @CHEMICAL_MESH:D008550 @@@melatonin@@@ significantly suppressed @<m>DISEASE_Carcinoma_Ehrlich_Tumor</m> @DISEASE_MESH:D002286 @@@Ehrlich tumor@@@ growth (by 40%, p < 0.001). ", "citations": {"NLM": "Anisimov VN, Egormin PA, Piskunova TS, Popovich IG, Tyndyk ML, Yurova MN, Zabezhinski MA, Anikin IV, Karkach AS, Romanyukha AA. Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle. 2010 Jan 1;9(1):188-97. PMID: 20016287", "BibTeX": "@article{20016287, title={Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo.}, author={Anisimov VN and Egormin PA and Piskunova TS and Popovich IG and Tyndyk ML and Yurova MN and Zabezhinski MA and Anikin IV and Karkach AS and Romanyukha AA}, journal={Cell Cycle}, volume={9}, number={1}, pages={188-97}}"}}]}